Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 4 1

Status

Completed 29Unknown 17Recruiting 6Terminated 4Withdrawn 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Venous Thromboembolism 1Stroke 1Skin Neoplasms 1Sarcoma 1Restless Legs Syndrome 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pituitary Neoplasms 1Parkinson Disease 1Odontogenic Cysts 1Multiple Sclerosis 1Migraine Disorders 1Localized Advanced Rectal Adenocarcinoma 1Keratosis, Actinic 1Inflammatory Bowel Diseases 1Hematoma 1Esophageal Neoplasms 1Epilepsy 1Dysbiosis 1Crohn Disease 1Colitis, Ulcerative 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Brain Concussion 1Bone Neoplasms 1

Interventions

Ropivacaine 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Enrolling by invitation × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all
NCT06711679 2024-12-02

Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia

Tongji Hospital

Phase 4 Enrolling by invitation
180 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡